OpenGamma LogoOpenGamma

Pricing

Choose your trading edge

Professional options flow analysis tools for every trader level

5-day trial available on request

Paid checkout starts access immediately. Trial access is approved manually before checkout so we can prevent abuse.

Request trial access

MCP Launch Promo

3 months for the price of 1

Limited founding beta access for members who want OpenGamma's read-only MCP workflow alongside daily structural market context. Enter the founding promo code in Stripe Checkout when you subscribe.

Research and decision-support context only. No execution, no signals, and no probability claims.
  • MCP member beta
  • Daily RTY / ES / NQ structural reports
  • GEX, Greeks, IV regime, and exact-DTE ladder context
  • Gann/Astro Lab as a research-only side module
  • ThetaData/LSQE evidence rail under construction, with no predictive claims

Essentials

Core options flow analysis tools

Paid access starts now
Need to try it first? A 5-day trial is available on request before checkout.

$19.99/month

  • GEX/DEX analysis
  • Open Interest data
  • Basic charts
  • Discord alerts
  • Email support

ProMost popular

Complete options analysis platform

Paid access starts now
Need to try it first? A 5-day trial is available on request before checkout.

$34.99/month

  • Full dashboard access
  • All indicators
  • Gamma heatmaps
  • IV surfaces
  • Futures levels
  • Vol trigger alerts
  • Priority support

Ultra

Advanced analytics and custom features

Paid access starts now
Need to try it first? A 5-day trial is available on request before checkout.

$89.99/month

  • Everything in Pro
  • API access
  • Regular Agentic AI Analysis
  • Advanced analytics
  • White-label options

Frequently Asked Questions

Can I change plans anytime?

Yes, you can upgrade or downgrade your plan at any time. Changes take effect immediately.

Is there a free trial?

A 5-day trial is available on request before checkout. We approve requests manually to prevent abuse; paid subscriptions start immediately unless a trial is approved separately.